CIK 0000715446
- Non-accelerated filer
- Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112622630
- Phone
- +1 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Open-market buy Director bought 900 shares at $3.31 ($2,979)
- 4 Open-market buy Director bought 500 shares at $3.60 ($1,800)
- 4 Open-market buy Director bought 2,000 shares at an average $3.36 ($6,710)
- 4 Open-market sale V.P., Finance & CFO sold 2,000 shares at an average $3.26 ($6,525)
- 4 Open-market buy Director bought 2,604 shares at an average $3.31 ($8,630)
- 4 Open-market buy Director bought 500 shares at an average $2.88 ($1,438)
- 4 Open-market buy Director bought 200 shares at $2.82 ($564)
- 4 Open-market buy Director bought 600 shares at an average $3.01 ($1,807)
- 4 Open-market buy Director bought 100 shares at $3.03 ($303)
- 4 Open-market buy Director bought 720 shares at $2.76 ($1,985)
- 4 Open-market buy Director bought 500 shares at $2.85 ($1,425)
- 4 Open-market buy Director bought 500 shares at $2.96 ($1,480)
- 4 Open-market buy Director bought 500 shares at $2.94 ($1,470)
- 4 Open-market buy Director bought 500 shares at $3.31 ($1,655)
- 4 Open-market buy Director bought 2,000 shares at $2.29 ($4,580)
- 4 Open-market buy Director bought 2,000 shares at an average $2.46 ($4,920)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 24 · 471 filings